Detalles de la búsqueda
1.
Effect of nesiritide versus dobutamine on short-term outcomes in the treatment of patients with acutely decompensated heart failure.
J Am Coll Cardiol
; 39(5): 798-803, 2002 Mar 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-11869844
2.
Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE).
Am Heart J
; 149(2): 209-16, 2005 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-15846257
3.
Effect of nesiritide (B-type natriuretic peptide) and dobutamine on ventricular arrhythmias in the treatment of patients with acutely decompensated congestive heart failure: the PRECEDENT study.
Am Heart J
; 144(6): 1102-8, 2002 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-12486437
4.
Safety and feasibility of using serial infusions of nesiritide for heart failure in an outpatient setting (from the FUSION I trial).
Am J Cardiol
; 94(5): 595-601, 2004 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-15342289
5.
Comparison of the effects of dobutamine and nesiritide (B-type natriuretic peptide) on ventricular ectopy in acutely decompensated ischemic versus nonischemic cardiomyopathy.
Am J Cardiol
; 91(11): 1370-2, 2003 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-12767439
6.
Subcutaneous administration of the cardiac hormone BNP in symptomatic human heart failure.
J Card Fail
; 10(2): 115-9, 2004 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-15101022
Resultados
1 -
6
de 6
1
Próxima >
>>